Corporate Governance

BDMS remains fully committed to operating under the principles of Good Corporate Governance, characterized by responsibility, ethical conduct, fairness, transparency and accountability. The company believes that a sound governance system serves as a critical mechanism to strengthen relationships among the Board of Directors, management, employees, shareholders and stakeholders, enabling the company to deliver appropriate and sustainable value to shareholders while responsibly addressing the interests of all stakeholder groups and reinforcing its position as a leading and sustainable healthcare provider.

In an increasingly complex and rapidly changing business environment, BDMS places strong emphasis on Board diversity by taking into account a broad range of perspectives, professional experiences and industry-specific expertise, which supports effective oversight, strategic guidance and well-informed decision making aligned with the company’s business context and long-term strategic direction.

Strategy and Management Approach

BDMS recognizes its roles, duties and responsibilities in conducting business under the principles of good corporate governance. The company believes that good corporate governance is a fundamental foundation for defining the structure and relationships among shareholders, the Board of Directors, management and all stakeholder groups. This approach enhances the company’s competitiveness and creates long-term value for shareholders, while giving due consideration to the interests of all stakeholders, thereby supporting the company’s continuous and sustainable growth.

Corporate Governance Policy

The company conducts its business with transparency, accountability and a commitment to building trust among stakeholders to support stable and sustainable long-term organizational growth. Accordingly, the Board of Directors has established a Corporate Governance Policy as a clear governance framework to serve as a common guideline for the Board of Directors, management and employees at all levels across the Group.

This policy and governance framework are designed in alignment with relevant laws, regulations, requirements and principles of good corporate governance at both national and international levels and comprise the following 5 key principles:

1. Section 1: Sustainable Value Creation
2. Section 2: Roles and Responsibilities of the Board of Directors
3. Section 3: Rights of Shareholders and Fair and Equitable Treatment of Shareholders
4. Section 4: Policy and Treatment of Stakeholders
5. Section 5: Information Disclosure and Transparency

For more information , please refer to Corporate Governance Policy

Corporate Governance Structure

BDMS has established a corporate governance structure that clearly defines the roles and responsibilities of the Board of Directors, subcommittees, management and internal governance units. This structure supports the company’s operations in compliance with applicable laws, regulations, shareholders’ resolutions and principles of good corporate governance.

The Board of Directors has appointed 5 subcommittees, namely:

1. Audit Committee
2. Nomination and Remuneration Committee
3. Executive Committee
4. Risk Management Committee
5. Corporate Governance and Sustainability Committee

These subcommittees are responsible for formulating and reviewing policies and monitoring performance within their respective scopes of responsibility. Policies and operational guidelines are communicated through senior management to ensure effective implementation and continuous performance monitoring across all levels of the organization. The subcommittees also support the establishment of operational policies, internal control systems, and corporate governance practices that are appropriate and aligned with relevant laws, regulations, and international standards.

Promoting a Strong Corporate Governance Culture

The company encourages directors, medical professionals, and employees to build awareness and understanding of the principles of good corporate governance, while continuously driving the communication of relevant policies and practices, such as the Corporate Governance Policy, Fraud Prevention and Anti-corruption Policy, Code of Conduct and Whistleblower Policy. These efforts aim to ensure transparent and accountable operations, reduce reputational risks, and strengthen trust among stakeholders, including patients, service recipients, shareholders, business partners, and society.

The company also emphasizes comprehensive policy communication to ensure that personnel clearly understand expected and prohibited conduct, as well as associated impacts and disciplinary measures. This helps reduce the risk of corruption, abuse of authority, and conflicts of interest.

As a result of these efforts, the company received an “Excellent” Corporate Governance Rating (5 stars) for 2025 under the Corporate Governance Report of Thai Listed Companies (CGR) conducted by the Thai Institute of Directors (IOD).

Anti-Corruption Practices and Complaint Management

Management Approach

BDMS conducts its business in accordance with the principles of good corporate governance, emphasizing transparency, fairness, ethical conduct, and accountability. The Company maintains a zero-tolerance stance toward all forms of corruption, as stipulated in its Code of Conduct.

In 2025,å the Company reviewed and updated its Fraud Prevention and Anti-corruption Policy to ensure alignment with applicable laws, regulations, and business-related requirements, as well as internationally recognized standards. The policy establishes reporting and complaint channels for violations of laws, unethical conduct, or activities that may constitute corruption.

The Company has implemented whistleblower protection measures and appropriate remediation mechanisms to mitigate potential adverse impacts. In parallel, various training programs and communication activities are conducted to enhance knowledge, understanding, and awareness among employees at all levels, as well as external stakeholders, regarding the Company’s anti-corruption policy. Clear whistleblower protection mechanisms have been established, together with strict disciplinary actions against individuals who engage in inappropriate behavior, intimidation, harassment, or discriminatory treatment toward whistleblowers.

The policy applies to the Board of Directors, executives, and employees at all levels and serves as a framework for preventing, mitigating, and addressing corruption risks within the organization. The Board of Directors actively promotes and communicates the policy to both internal and external stakeholders through appropriate communication channels.

Fraud Prevention and Anti-corruption Policy

BDMS places great importance on conducting business with transparency, fairness, ethics, and accountability, guided by the principles of Good Corporate Governance and responsibility toward all stakeholder groups. Accordingly, the Company has established an Anti-Corruption Policy as a framework for directors, executives, and employees across the Group. The policy adopts a strict zero-tolerance approach to all forms of corruption, whether direct or indirect.

The Company systematically manages corruption risks through risk assessments, risk prioritization, and regular internal audits to ensure compliance with applicable laws, regulations, and good corporate governance standards. Comprehensive internal control measures are implemented across key business processes, including procurement, contract management, disbursements, and financial recordkeeping. Clear approval authorities and supporting documentation requirements are established to enhance transparency and accountability.

In conducting business, the Company has established guidelines governing charitable donations, community contributions, business hospitality, and the giving or receiving of gifts. Such activities must be conducted appropriately and transparently and must not serve as a means of obtaining improper benefits or facilitating bribery. BDMS also maintains political neutrality and does not provide financial support or other benefits to political parties, politicians, or election candidates, thereby minimizing corruption and conflict-of-interest risks.

To foster a culture of integrity, the Company continuously communicates its anti-corruption policies and measures through training programs, meetings, intranet systems, and other internal communication channels. Training is also provided to enhance awareness and understanding among employees and relevant stakeholders regarding corruption risks, forms of misconduct, and preventive measures.

BDMS has established Whistleblowing Channels for reporting activities that may violate laws, ethical standards, or anti-corruption requirements. Reports can be submitted through multiple channels, and whistleblowers are protected under the Company’s Whistleblower Protection Policy, which includes confidentiality safeguards, anonymity protection, and protection against retaliation or harassment. All complaints are investigated fairly and transparently, and disciplinary actions are taken against offenders or individuals who retaliate against whistleblowers.

The Company accepts reports relating to the following matters:

• Violations of laws, fraud, Company regulations, or the Employee Code of Conduct
• Violations of the Board of Directors’ Code of Conduct
• Violations of medical ethics
• Irregularities in financial reporting
• Issues that may adversely affect the Company’s reputation and corporate image

Complaint /Notification Channels

The Audit Committee plays a key role in overseeing compliance with the policy, reviewing the adequacy of internal control systems, and reporting issues that may affect business transparency to the Board of Directors for timely corrective action. The Company regularly reviews and updates its anti-corruption policies and measures to ensure alignment with evolving laws, international standards, and sustainability-related best practices, thereby supporting transparent, responsible, and sustainable long-term growth.

In 2025, the Company recorded zero significant incidents of corruption or bribery. There were no legal cases, lawsuits, judgments, fines, or sanctions related to corruption or bribery imposed by regulatory authorities. This reflects the effectiveness of the Company’s governance framework, risk management processes, and anti-corruption measures.

Complaint and Corruption Reporting Channels

---

Postal Mail

Corporate Human Resources Department

Bangkok Bangkok Dusit Medical Services Public Co.,Ltd.

2 Soi Soonvijai 7, New Phetchaburi Rd. Bang Kapi, Bangkok 10310 Thailand

BDMS Code of Conduct

BDMS has established a Business Code of Conduct to demonstrate its commitment to responsible business operations and the achievement of corporate objectives. Employees are required to understand and acknowledge the relevant requirements and guidelines, which serve as the framework for their professional conduct and decision-making.

The Code is founded on the principles of

1. Observing the Law
2. Political Action
3. Maintaining Corporate Assets
4. Personal Conduct and Conduct towards other Employees
5. Conflicts of Interest
6. Giving and Receiving Gifts
7. Confidentiality and Use of Internal Information
8. Fairness
9. Safe, Health, and Environment

The rule of law, compliance with applicable laws, regulations, and good corporate governance practices, while respecting the environment, customs, traditions, and cultures of each country in which the Company operates. BDMS upholds morality, ethics, and integrity as core values and applies good governance principles throughout its business operations.

Management of Code of Conduct Violations

BDMS has established a systematic process for managing Code of Conduct violations under the supervision of the Central Human Resources Division and the Corporate Employee Ethics Committee. This ensures that investigations and disciplinary actions are conducted transparently, fairly, and accountably.

The Company provides channels for reporting suspected violations or unethical conduct. All reported cases are carefully investigated. Where allegations are substantiated, an investigation committee is appointed to determine appropriate corrective measures or disciplinary actions in accordance with Company regulations.

In addition, the Company promotes ethical awareness and an integrity-based culture through continuous communication, training programs, and employee knowledge assessments. Lessons learned and performance outcomes are communicated to prevent recurrence and strengthen ethical standards across the organization.

Disciplinary decisions take into consideration the nature of the misconduct, intent, severity, resulting impacts, and opportunities for corrective action, in line with principles of good governance, fairness, and accountability.

Whistleblower Protection and Remediation

BDMS places significant importance on protecting whistleblowers, complainants, and individuals who cooperate in investigations. Strict confidentiality and personal data protection measures are implemented. Complainants may choose to remain anonymous, and information is disclosed only on a need-to-know basis within the investigation process.

The Company is committed to ensuring that individuals who report concerns in good faith are protected from retaliation, discrimination, harassment, unfair disciplinary action, or wrongful termination. In cases where individuals suffer hardship or damages resulting from reported incidents, the Company provides appropriate and equitable remediation and assistance based on the circumstances of each case.